Greene LJ, Camargo AC, Krieger EM, Stewart JM, Ferreira SHInhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom. Circ Res1972;31 (suppl 2):62-71.
2.
Nguyen G., Delarue F., Burcklé C., Bouzhir L., Giller T., Sraer JDPivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest2002;109:1417-27.
3.
Ludwig J., Kerscher S., Brandt U. et al. Identification and characterisation of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules . J Biol Chem1998;273:10939-47.
4.
Schefe JH, Menk M., Reinemund J. et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res2006;99:1355-66.
5.
Ichihara A., Suzuki F., Nakagawa T. et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol2006;17:1950-61.
6.
Feldt S., Maschke U., Dechend R., Luft FC, Muller DNThe putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling . J Am Soc Nephrol2008;[Epub ahead of print]
7.
Muller DN, Klanke B., Feldt S. et al. (Pro)renin receptor peptide inhibitor `handle-region` peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertens2008;51:676-81.
8.
Feldt S., Batenburg WW, Mazak I. et al. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertens2008;22:[Epub ahead of print]
9.
Batenburg WW , Krop M., Garrelds IM et al. Prorenin is the endogenous agonist of the (pro)renin receptor. Bindings kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor . J Hypertens2007;25:2441-53.
10.
Robertson AL Jr, Khairallah PAAngiotenisn II: rapid localization in nuclei of smooth and cardiac muscle. Science1971 ;172:1138-9.
11.
Kumar R., Singh VP, Bake KMThe intracellular reninangiotensin system: implications in cardiovascular angiotensin system: implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens2008;17:168-73.
12.
Haller H., Lindschau C., Erdmann B., Quass P., Luft FCEffects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res1996;79:765-72.
13.
Lambert DW, Hooper NM, Turner AJAngiotensin-converting enzyme 2 and new insights into the renin-angiotensin system. Biochem Pharmacol2008;75:781-6.
14.
Raizada MK, Ferreira AJACE 2: a new target for cardiovascular disease therapuetics. J Cardiovasc Pharmacol2007;50:112-19.
15.
Feng Y., Yue X., Xia H. et al. Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor down-regulation. Circ Res2008;[Epub ahead of print]
16.
Wu P., Costa-Gonalves AC, Todiras M. et al. Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice. Hypertension2008;51:574-80.
17.
van der Wouden EA, Ochodnick P., van Dokkum RP et al. The role of angiotensin(1-7) in renal vasculature of the rat. J Hypertens2006;24:1971-8.
18.
Nagata S., Kato J., Sasaki K., Minomino N., Eto T., Kitamura K.Isolation and identification of proangiotensin-1-12, a possible component of the renin-angiotensin system. Biochem Biophy Res Commun2006;350:1026-31.
19.
Sharma U., Rhaleb NE, Pokharel S. et al. Novel antiinflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. Am J Physiol Heart Circ Physiol2008;[Epub ahead of print].
20.
Lu H., Rateri DL, Feldman DL et al. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest2008;[Epub ahead of print].
21.
Kobori H., Nangaku M., Navar LG, Nishiyama A.The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev2007;59:251-87.
22.
Souza PP, Fukada SY, Cunha FQ, Costa CA, Costa-Neto CMRegulation of angiotensin II receptors levels during rat induced pulpitis . Regul Pept2007;140(1-2):27-31.
23.
Padia SH, Kemp BA, Howell NL, Fournie-Zaluski MC, Roques BP, Carey RMConversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats. Hypertens2008;51:460-5.
24.
Ceravolo GS , Fernandes L., Munhoz CD et al. Angiotensin II chronic infusion induces B1 receptor expression in aorta of rats. Hypertens2007;50:756-61.
25.
Gassanov N. , Devost D., Danalache B. et al. Functional activity of the carboxyl-terminally extended oxytocin precursor Peptide during cardiac differentiation of embryonic stem cells. Stem Cells2008;26(1):45-54.
26.
Meirovich YF , Veinot JP, de Bold ML et al. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant2008;27(1):31-7.
27.
Zhou MS, Hernandez Schulman I. , Pagano PJ, Jaimes EA, Raij L.Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertens2006;47(1):81-6.
28.
Huang R., Karve A., Shah I. et al. Deletion of the mouse {alpha}-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia/reperfusion Injury. Am J Physiol Heart Circ Physiol2008;[Epub ahead of print].
29.
Liberman M. , Bassi E., Martinatti MK et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol2007;[Epub ahead of print].
30.
Hilgers RH, Todd J. Jr, Webb RCIncreased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats. J Hypertens2007;25:1687-97.
31.
Hercule HC, Tank J., Plehm R. et al. Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice. Exp Physiol2007;92:1014-22.
32.
Okruhlicova L., Morwinski R., Schulze W. et al. Autoantibodies against G-protein-coupled receptors modulate heart mast cells. Cell Mol Immunol2007;4:127-33.